Life expectancy in HIV-positive persons in Switzerland-Reference-Cited by-同舟云学术

Life expectancy in HIV-positive persons in Switzerland

Published:2017-01-28 Issue:3 Volume:31 Page:427-436
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Gueler Aysel,Moser André,Calmy Alexandra,Günthard Huldrych F.,Bernasconi Enos,Furrer Hansjakob,Fux Christoph A.,Battegay Manuel,Cavassini Matthias,Vernazza Pietro,Zwahlen Marcel,Egger Matthias

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference40 articles.

1. Life expectancy in the immune recovery era: the evolving scenario of the HIV epidemic in northern Italy;Guaraldi;J Acquir Immune Defic Syndr,2014

2. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada;Samji;PLoS One,2013

3. ATHENA national observational cohort study. Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals;van Sighem;AIDS,2010

4. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies.;Lancet,2008

5. Survival of persons with and without HIV infection in Denmark, 1995–2005;Lohse;Ann Intern Med,2007

Cited by 213 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implementation of routine HIV testing policy in medical admissions in the sultanate of Oman: An experience from the Middle East;International Journal of STD & AIDS;2024-09-11

2. Role of the pharmacist caring for people at risk of or living with HIV in Canada;Canadian Pharmacists Journal / Revue des Pharmaciens du Canada;2024-08-02

3. Potential healthcare resource use and associated costs of every 2 month injectable cabotegravir plus rilpivirine long-acting regimen implementation in the Spanish National Healthcare System compared to daily oral HIV treatments;BMC Infectious Diseases;2024-08-02

4. Survival among people with HIV and their families in Denmark 1995–2021: a nationwide population-based cohort study;The Lancet Regional Health - Europe;2024-08

5. Decoupling HIV-1 antiretroviral drug inhibition from plasma antibody activity to evaluate broadly neutralizing antibody therapeutics and vaccines;Cell Reports Medicine;2024-08